These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28612644)

  • 1. Methods to analyze big data in pharmacogenomics research.
    Li R; Kim D; Ritchie MD
    Pharmacogenomics; 2017 Jun; 18(8):807-820. PubMed ID: 28612644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics: Precision Medicine and Drug Response.
    Weinshilboum RM; Wang L
    Mayo Clin Proc; 2017 Nov; 92(11):1711-1722. PubMed ID: 29101939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering next-generation pharmacogenomics: an information technology perspective.
    Potamias G; Lakiotaki K; Katsila T; Lee MT; Topouzis S; Cooper DN; Patrinos GP
    Open Biol; 2014 Jul; 4(7):. PubMed ID: 25030607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of the DruGeVar Database in Cancer Genomics and Pharmacogenomics.
    Sarris K; Komianou A; Patrinos GP; Katsila T
    Public Health Genomics; 2017; 20(2):142-147. PubMed ID: 28704821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementing genomics and pharmacogenomics in the clinic: The National Human Genome Research Institute's genomic medicine portfolio.
    Manolio TA
    Atherosclerosis; 2016 Oct; 253():225-236. PubMed ID: 27612677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and Opportunities of Genomic Approaches in Therapeutics Development.
    Gray JS; Campbell MJ
    Methods Mol Biol; 2021; 2194():107-126. PubMed ID: 32926364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric perspective on pharmacogenomics.
    Stevens A; De Leonibus C; Hanson D; Whatmore A; Murray P; Donn R; Meyer S; Chatelain P; Clayton P
    Pharmacogenomics; 2013 Nov; 14(15):1889-905. PubMed ID: 24236488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the clinic: 'direct-to-consumer' genomic profiling services and pharmacogenomics.
    Prainsack B; Vayena E
    Pharmacogenomics; 2013 Mar; 14(4):403-12. PubMed ID: 23438887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Big data in pharmacogenomics: current applications, perspectives and pitfalls.
    Barrot CC; Woillard JB; Picard N
    Pharmacogenomics; 2019 Jun; 20(8):609-620. PubMed ID: 31190620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity.
    Chan SL; Jin S; Loh M; Brunham LR
    Pharmacogenomics; 2015; 16(10):1161-78. PubMed ID: 25978008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics and pharmacogenomics: development, science, and translation.
    Weinshilboum RM; Wang L
    Annu Rev Genomics Hum Genet; 2006; 7():223-45. PubMed ID: 16948615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics research involving racial classification: qualitative research findings on researchers' views, perceptions and attitudes towards socioethical responsibilities.
    Egalité N; Ozdemir V; Godard B
    Pharmacogenomics; 2007 Sep; 8(9):1115-26. PubMed ID: 17924827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics and pharmacogenomics in the discovery and development of medicines.
    Roses AD
    Novartis Found Symp; 2000; 229():63-6; discussion 66-70. PubMed ID: 11084930
    [No Abstract]   [Full Text] [Related]  

  • 14. Institutional profile: translational pharmacogenomics at the Icahn School of Medicine at Mount Sinai.
    Scott SA; Owusu Obeng A; Botton MR; Yang Y; Scott ER; Ellis SB; Wallsten R; Kaszemacher T; Zhou X; Chen R; Nicoletti P; Naik H; Kenny EE; Vega A; Waite E; Diaz GA; Dudley J; Halperin JL; Edelmann L; Kasarskis A; Hulot JS; Peter I; Bottinger EP; Hirschhorn K; Sklar P; Cho JH; Desnick RJ; Schadt EE
    Pharmacogenomics; 2017 Oct; 18(15):1381-1386. PubMed ID: 28982267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics considerations in the control of hypertension.
    Lupoli S; Salvi E; Barcella M; Barlassina C
    Pharmacogenomics; 2015 Nov; 16(17):1951-64. PubMed ID: 26555875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics, pharmacogenomics and airway disease.
    Hall IP
    Respir Res; 2002; 3(1):10. PubMed ID: 11806845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomewide Association Studies in Pharmacogenomics: Meeting Report of the NIH Pharmacogenomics Research Network-RIKEN (PGRN-RIKEN) Collaboration.
    Yee SW; Momozawa Y; Kamatani Y; Tyndale RF; Weinshilboum RM; Ratain MJ; Giacomini KM; Kubo M
    Clin Pharmacol Ther; 2016 Nov; 100(5):423-426. PubMed ID: 27256705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convergent Functional Genomics of bipolar disorder: from animal model pharmacogenomics to human genetics and biomarkers.
    Le-Niculescu H; McFarland MJ; Mamidipalli S; Ogden CA; Kuczenski R; Kurian SM; Salomon DR; Tsuang MT; Nurnberger JI; Niculescu AB
    Neurosci Biobehav Rev; 2007; 31(6):897-903. PubMed ID: 17614132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics: historical perspective and current status.
    Charlab R; Zhang L
    Methods Mol Biol; 2013; 1015():3-22. PubMed ID: 23824846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic medicine implementation: learning by example.
    Williams MS
    Am J Med Genet C Semin Med Genet; 2014 Mar; 166C(1):8-14. PubMed ID: 24616394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.